Teva Pharmaceuticals sued Jazz Pharmaceuticals (NASDAQ: JAZZ) over the patents for the cannabis drug Epidiolex which is used to treat rare pediatric epilepsy conditions known as Lennox-Gastaut syndrome, Davaut syndrome, and tuberous sclerosis complex. However, a judge has rejected the argument that Jazz wasn’t truthful when applying for the patents.
Read the full report
https://www.greenmarketreport.com/judge-not-swayed-in-patent-battle-over-epidiolex-patents/
Sean Hocking
Source link
